TEAMS: Tele-Exercise and Multiple Sclerosis

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03117881
Collaborator
Patient-Centered Outcomes Research Institute (Other), Alabama Neurology Associates, PC (Other), Lakeshore Foundation (Other)
912
40
3
60.7
22.8
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the effects of two delivery models of an evidence-based complementary alternative medicine (CAM) program that combines neurorehabilitative (functional) exercise, yoga, and Pilates for adults age 18-70 with multiple sclerosis (MS). CAM will be delivered as a 12-week program through two different delivery forms: On-site at a clinic (DirectCAM) and telerehabilitation (TeleCAM). Participants will be randomly assigned to one of these two groups.

On March 16th, 2020, the University of Alabama at Birmingham halted all onsite non-essential research in response to the Covid-19 pandemic. Since then, the study has begun to conduct all testing remotely through videoconferencing technology. In addition, another study group, remote DirectCAM (rDirectCAM), has been incorporated into the study to continue the 12-week program delivery for newly recruited participants via videoconferencing technology.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: DirectCAM
  • Behavioral: TeleCAM
  • Behavioral: rDirectCAM
N/A

Detailed Description

There are few primary care and multiple sclerosis (MS) clinics that provide full exercise and rehabilitation services for patients with MS, especially in mostly rural, low-income areas such as Alabama, Mississippi, and Tennessee. Telerehabilitation, or the delivery of rehabilitation services over the telephone and/or the Internet, can help fill service gaps for underserved MS patient populations in this region. The proposed study will determine if our evidence-based rehabilitation and exercise program produces similar health outcomes when delivered in clinic or at home, using pre-loaded tablets and Interactive Voice Response (IVR) system technology among 759 participants with MS from 40 clinics across Alabama, Mississippi, and Tennessee.

In response to the Covid-19 pandemic, the study aims to recruit 74 participants with MS into the rDirectCAM, where the 12-week program is delivered in real-time via videoconferencing technology. The rDirectCAM will determine if a telehealth rehabilitation program can have a similar effect as when the program is offered in person.

The outcomes that we hope to achieve through the proposed rehabilitation and exercise program, referred to as complementary alternative medicine, are improved physical activity, decreased pain and fatigue, and quality of life. We also seek to improve attitudes and behaviors related to physical activity, such as outcome expectations for physical activity, social support from family and friends for physical activity, self-efficacy (i.e., confidence in one's ability to be active), and self-regulation (i.e., setting exercise goals). We will examine the variation in outcomes by patient characteristics such as age and severity of disability to determine for whom the intervention is effective.

This project is important to patients with MS because it seeks to reduce their barriers to receiving exercise treatment and increase the convenience and appeal of such programs through technology. Furthermore, findings and resources from this study will be quickly provided to MS patients and clinicians across the United States (e.g., via training webinars through our National Center on Health, Physical Activity, and Disability [NCHPAD]) and thereby improve the quality and reach of exercise treatment for patients with MS.

The patient and stakeholder partners include MS patients, caretakers, and clinicians, who have been actively guiding the development of this project. In stakeholder meetings, members have provided insight into exercise treatment needs and preferences (e.g., individually tailored approaches that account for varying levels of mobility); outcomes of interest to the patient population (e.g., pain, fatigue, quality of life); and strategies for engaging/motivating participants with MS who may be discouraged and experiencing fatigue and pain (e.g., IVR calls and feedback). Moreover, their ongoing program satisfaction feedback will be important to our recruitment and retention success. Finally, the stakeholders will help make this project successful by continuing to emphasize the importance of long-term gains in health outcomes and promote (through NCHPAD) the sustainability of the program.

Study Design

Study Type:
Interventional
Actual Enrollment :
912 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Comparative Effectiveness Trial Between a Clinic- and Home-Based Complementary and Alternative Medicine Telerehabilitation Intervention for Adults With Multiple Sclerosis (MS)
Actual Study Start Date :
Jan 8, 2018
Actual Primary Completion Date :
Oct 30, 2021
Anticipated Study Completion Date :
Jan 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: DirectCAM

The DirectCAM arm receives the intervention content via therapists at participating clinics.

Behavioral: DirectCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks at a clinic with a therapist. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using handouts.

Experimental: TeleCAM

The TeleCAM arm receives the intervention content at home using pre-loaded tablets and Interactive Voice Response (IVR) system technology.

Behavioral: TeleCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks at home via videos. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using the videos.

Experimental: rDirectCAM

The rDirectCAM arm is being implemented in response to Covid-19. The rDirectCAM arm receives the intervention content delivered remotely in real-time by therapists via videoconferencing technology.

Behavioral: rDirectCAM
The intervention consists of a 60-minute Complementary Alternative Medicine (CAM) program that includes yoga, Pilates and dual-functioning exercises, which is delivered 2 times per week for the first 8 weeks and 1 time per week for the following 4 weeks by a therapist via videoconferencing technology. At the end of week 12, participants will be asked to continue the program in their home for up to 1 year post-intervention using handouts.

Outcome Measures

Primary Outcome Measures

  1. Change in Baseline Pain at Month 3 and Month 12 [48 weeks]

    Measured by 36-Item Short Form Survey (SF-36).

  2. Change in Baseline Fatigue at Month 3 and Month 12 [48 weeks]

    Measured by Modified Fatigue Impact Scale (MFIS).

  3. Change in Baseline Quality of Life at Month 3 and Month 12 [48 weeks]

    Measured by 36-Item Short Form Survey (SF-36).

  4. Change in Baseline Physical Activity at Month 3 and Month 12 [48 weeks]

    Measured by the Godin Leisure Time Exercise Questionnaire (GLTEQ).

Secondary Outcome Measures

  1. Change in Baseline Balance at Month 3 and Month 12 [48 weeks]

    Measured using the Berg Balance Scale (BBS).

  2. Change in Baseline Endurance at Month 3 and Month 12 [48 weeks]

    Measured using the 6-minute Walk Test (6MWT).

  3. Change in Baseline Gait at Month 3 and Month 12 [48 weeks]

    Measured using the Timed 25-Foot Walk (T25-FW).

  4. Change in Baseline Strength at Month 3 and Month 12 [48 weeks]

    Measured using a hand-held dynamometer.

Other Outcome Measures

  1. Outcome expectations for exercise [48 weeks]

    Measured by the Multidimensional Outcome Expectations for Exercise Scale (MOEES).

  2. Exercise self-efficacy [48 weeks]

    Measured by the Exercise Self-efficacy Scale.

  3. Social support for exercise [48 weeks]

    Measured by the Social Provisions Scale.

  4. Exercise self-regulation [48 weeks]

    Measured by the Exercise Goal-setting Scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Physician permission to participate in the study

  • Mild to moderate disability (i.e., ambulate with/without assistive device, Patient-Determined Disease Steps [PDDS] 0 - 7

  • Able to use arms/legs for exercise

Exclusion Criteria:
  • Significant visual acuity that prevents seeing a tablet screen to follow home exercise program

  • Cardiovascular disease event within the last six months, several pulmonary disease, and/or renal failure

  • Active pressure ulcers

  • Currently pregnant

  • Within 30 days of receiving a rehabilitation program

  • Already meeting physical activity guidelines (GLTEQ > 24)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Upstream Rehabilitation Inc. Athens Alabama United States 35613
2 Upstream Rehabilitation Inc. Bessemer Alabama United States 35022
3 Tanner Foundation Birmingham Alabama United States 35209
4 Upstream Rehabilitation Inc. Calera Alabama United States 35040
5 Upstream Rehabilitation Inc. Cullman Alabama United States 35058
6 Southeast Alabama Medical Center Rehabilitation Services Dothan Alabama United States 36301
7 Gulf Coast Therapy Fairhope Alabama United States 36532
8 Gulf Coast Therapy Foley Alabama United States 36536
9 Encore Rehabilitation Fort Payne Alabama United States 35967
10 Upstream Rehabilitation Inc. Gadsden Alabama United States 35906
11 Therapy Achievements Huntsville Alabama United States 35801
12 Upstream Rehabilitation Inc. Jacksonville Alabama United States 36265
13 Upstream Rehabilitation Inc. Jasper Alabama United States 35501
14 Gulf Coast Therapy Mobile Alabama United States 36607
15 Montgomery East Physical Therapy Montgomery Alabama United States 36117
16 Upstream Rehabilitation Inc. Muscle Shoals Alabama United States 35674
17 Encore Rehabilitation Phenix City Alabama United States 36867
18 Upstream Rehabilitation Inc. Tuscaloosa Alabama United States 35046
19 Cornerstone Rehabilitation Batesville Mississippi United States 38668
20 Upstream Rehabilitation Inc. Byram Mississippi United States 39272
21 Upstream Rehabilitation Inc. Canton Mississippi United States 39046
22 Upstream Rehabilitation Inc. Columbus Mississippi United States 39702
23 Upstrem Rehabilitation Forest Mississippi United States 39074
24 Upstream Rehabilitation Inc. Fulton Mississippi United States 38843
25 River City Rehabilitation Greenville Mississippi United States 38703
26 Encore Rehabilitation Grenada Mississippi United States 38901
27 Upstream Rehabilitation Inc. Hattiesburg Mississippi United States 39402
28 Methodist Rehabilitation Center Jackson Mississippi United States 39216
29 Encore Rehabilitation Ocean Springs Mississippi United States 39564
30 North Sunflower Medical Center Ruleville Mississippi United States 38771
31 Cornerstone Rehabilitation Southaven Mississippi United States 38671
32 Upstream Rehabilitation Inc. Starkville Mississippi United States 39759
33 Upstream Rehabilitation Inc. Tupelo Mississippi United States 38801
34 Cornerstone Rehabilitation Water Valley Mississippi United States 38965
35 Upstream Rehabilitation Inc. Bristol Tennessee United States 37620
36 Upstream Rehabilitation Inc. Cool Springs Tennessee United States 37067
37 Upstream Rehabilitation Inc. Gordonsville Tennessee United States 38563
38 Upstream Rehabilitation Inc. Knoxville Tennessee United States 37931
39 Upstream Rehabilitation Inc. Newport Tennessee United States 37821
40 Upstream Rehabilitation Inc. Winchester Tennessee United States 37398

Sponsors and Collaborators

  • University of Alabama at Birmingham
  • Patient-Centered Outcomes Research Institute
  • Alabama Neurology Associates, PC
  • Lakeshore Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
James Rimmer, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT03117881
Other Study ID Numbers:
  • F161017003
  • MS-1511-33653
First Posted:
Apr 18, 2017
Last Update Posted:
Dec 7, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by James Rimmer, Principal Investigator, University of Alabama at Birmingham
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 7, 2021